Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Wei Lin

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumanniiJinxin Zhao, Yan Zhu, Yu-Wei Lin, et al.
British Journal of Clinical Pharmacology|August 19, 2024
Exposure-response modelling of osimertinib in patients with non-small cell lung cancerMartin Johnson, Yu-Wei Lin, Henning Schmidt, et al.
International Journal of Pharmaceutics|December 10, 2019
Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infectionsShihui Yu, Shaoning Wang, Peizhi Zou, et al.
International Journal of Antimicrobial Agents|May 14, 2025
Microfluidic evolution-on-a-chip reveals distinct evolution of polymyxin resistance associated with fitness optimum in Acinetobacter baumanniiJinxin Zhao, Yaqi Zhang, Yu-Wei Lin, et al.
Frontiers in Pharmacology|December 29, 2022
Editorial: Model-informed drug development and evidence-based translational pharmacologyJinxin Zhao, Xiao Zhu, Songwen Tan, et al.
BMC Cancer|July 14, 2016
Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinomaJenny Que, Hsing-Tao Kuo, Li-Ching Lin, et al.
Frontiers in Veterinary Science|June 18, 2026
A multicenter retrospective analysis of canine idiopathic epilepsy in ChinaXing-Wang Zhang, Yu-Cheng Guan, Zhi-Jiang Liu, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection ModelYu-Wei Lin, Qi Zhou, Nikolas J Onufrak, et al.
International Journal of Antimicrobial Agents|September 21, 2025
A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolateAneeq Farooq, Sue C Nang, Heidi H Yu, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Role of Herbal Extracts of Catechu from <i>Uncaria gambir</i> in the Treatment of Chronic Diabetic WoundsTsung-Jung Ho, Pei-Hsuan Tsai, Chia-Ho Hsieh, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2022
Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumanniiJinxin Zhao, Yan Zhu, Yu-Wei Lin, et al.
British Journal of Clinical Pharmacology|August 19, 2024
Exposure-response modelling of osimertinib in patients with non-small cell lung cancerMartin Johnson, Yu-Wei Lin, Henning Schmidt, et al.
International Journal of Pharmaceutics|December 10, 2019
Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infectionsShihui Yu, Shaoning Wang, Peizhi Zou, et al.
International Journal of Antimicrobial Agents|May 14, 2025
Microfluidic evolution-on-a-chip reveals distinct evolution of polymyxin resistance associated with fitness optimum in Acinetobacter baumanniiJinxin Zhao, Yaqi Zhang, Yu-Wei Lin, et al.
Frontiers in Pharmacology|December 29, 2022
Editorial: Model-informed drug development and evidence-based translational pharmacologyJinxin Zhao, Xiao Zhu, Songwen Tan, et al.
BMC Cancer|July 14, 2016
Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinomaJenny Que, Hsing-Tao Kuo, Li-Ching Lin, et al.
Frontiers in Veterinary Science|June 18, 2026
A multicenter retrospective analysis of canine idiopathic epilepsy in ChinaXing-Wang Zhang, Yu-Cheng Guan, Zhi-Jiang Liu, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection ModelYu-Wei Lin, Qi Zhou, Nikolas J Onufrak, et al.
International Journal of Antimicrobial Agents|September 21, 2025
A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolateAneeq Farooq, Sue C Nang, Heidi H Yu, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Role of Herbal Extracts of Catechu from <i>Uncaria gambir</i> in the Treatment of Chronic Diabetic WoundsTsung-Jung Ho, Pei-Hsuan Tsai, Chia-Ho Hsieh, et al.
Pageof 17